Showing results (291-300 of 356) with videos related to
Sort By:
Pageof 36
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2020
ANG1005, a Brain-Penetrating Peptide-Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain MetastasesPriya Kumthekar, Shou-Ching Tang, Andrew J Brenner, et al.Future Oncology (London, England)|August 11, 2022
BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumorsSantosh Kesari, Alberto Bessudo, Brian R Gastman, et al.Oncoimmunology|November 22, 2024
Pre-radiation Nivolumab plus ipilimumab in patients with newly diagnosed high-grade gliomasSantosh Kesari, Alexandre Wojcinski, Sarabjot Pabla, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Phase II study of protracted daily temozolomide for low-grade gliomas in adultsSantosh Kesari, David Schiff, Jan Drappatz, et al.Human Vaccines & Immunotherapeutics|September 12, 2025
Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survivalDaniela A Bota, David E Piccioni, Christopher M Duma, et al.The Journal of Experimental Medicine|April 6, 2011
A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomasSameer Agnihotri, Amparo Wolf, Diana M Munoz, et al.Journal for Immunotherapy of Cancer|February 4, 2022
Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapyJoanne Weidhaas, Nicholas Marco, Aaron W Scheffler, et al.Translational Medicine Communications|August 30, 2021
Correction to: Mesenchymal stem cells in the treatment of severe COVID-19Santosh Kesari, Gregory C Kasper, Lev Verkh, et al.Plos One|June 10, 2010
Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapyMasayuki Nitta, David Kozono, Richard Kennedy, et al.Journal of Neuro-Oncology|June 20, 2014
Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort studyBrian J Scott, Vincent A van Vugt, Toni Rush, et al.Pageof 36